Creating a New Health Promotion Module to Help the Indigenous People of Selangor Prepare for Disease X and Outbreaks

April 12, 2025 updated by: Ameerah Su'ad binti Abdul Shakor, Universiti Teknologi Mara

Development and Effectiveness of a New Intervention on Household Preparedness for Disease X and Outbreaks Among Orang Asli in Selangor: A Cluster Randomized Trial

The goal of this cluster randomized trial is to develop and test a new method for preparing indigenous (locally termed as Orang Asli) households in Selangor, a state in Malaysia, for outbreaks and Disease X, a potential unknown infectious threat. It aims to determine if the new method, a health education package comprised of workshops, simulation exercises, and card game play sessions, can enhance the readiness of these families for such outbreaks.

The main questions it is looking to answer are:

  1. Will the intervention package increase the level of preparedness for a Disease X and outbreaks among indigenous households in Selangor?
  2. Will the intervention improve the awareness and attitudes of the indigenous people in Selangor towards outbreak preparedness?
  3. Will it lead to more proactive preparedness actions by these households?

To evaluate the effectiveness of the intervention package, researchers will compare outcomes between two groups: the intervention group receiving both the intervention package and educational brochures on communicable disease prevention, and the control group receiving only the brochures.

Participants will:

  1. Participate in the activities in the newly developed intervention package, which would include workshops, simulation exercises, and card game play sessions.
  2. Answer surveys four times: before, immediately after, 1 month after and 2 months after the intervention, to measure any changes in their preparedness levels for an outbreak.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Selangor
      • Gombak, Selangor, Malaysia, 53100
        • Enrolling by invitation
        • Pejabat JAKOA Daerah Gombak dan Petaling
      • Gombak, Selangor, Malaysia, 53100
        • Recruiting
        • Pejabat JAKOA Daerah Gombak dan Petaling
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Orang Asli ethnicity
  • Malaysian citizen
  • Age between 18 to 99 years old
  • The head of the household, or the person who contributes to, or influences health-related decisions for the household
  • Live in a household with at least three members
  • Able to converse in Malay

Exclusion Criteria:

  • Having physical or cognitive disabilities (e.g., blindness, deafness, schizophrenia and dementia)
  • Having severe health conditions (e.g., respiratory and cardiovascular disease requiring oxygen support such as severe asthma/chronic obstructive pulmonary disease/heart failure and congenital heart diseases)
  • Residing temporarily (less than 2 years)
  • Intending to relocate to a different residence within the next 2 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Randomly selected Orang Asli villages will receive the intervention package along with educational brochures, through a workshop they will need to participate in once.
The chosen villages will be given the intervention package, which includes a workshop, simulation exercises, and a card game, in addition to educational brochures on communicable disease prevention sourced from the Ministry of Health Malaysia "Info Sihat" website. This entire package will be delivered once, during the workshop, after they have answered the survey at T0.
Active Comparator: Control
Randomly selected Orang Asli villages that will receive the educational brochures only.
The chosen villages will be given educational brochures on communicable disease prevention sourced from the Ministry of Health Malaysia "Info Sihat" website. This will be given once during the first encounter with the participant, after they have answered the survey at T0.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Household Preparedness Score
Time Frame: Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)
The combined scores of awareness/attitude and the preparedness actions of the participant in a specific area towards potential disasters. The preparedness level is measured on a 4-category scale: Fully prepared, Committed, Aware, and Least prepared or unprepared.
Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)
Household Preparedness Matrix
Time Frame: Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)
Based on the "Household Preparedness Score", the level of preparedness by assigning each respondent a position on the matrix based on their questionnaire responses.
Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive Preparedness score
Time Frame: Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)
Measures the knowledge and attitude of participant regarding outbreak and Disease X awareness Additionally, gathering insights about people's perception of possible risk hazard that may affect them including the consequences and how to mitigate. The score is derived from the total sum of marks gathered from each item within the Knowledge and Attitude domain and normalized into a scale of 0 to 1.
Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)
Preparedness Behaviour score
Time Frame: Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)
Measures the current level of preparedness actions that has been done by participants. The score is derived from the total sum of marks gathered from each item within the Practice domain and normalized into a scale of 0 to 1.
Before intervention (T0), immediately after the intervention (T1), 1-month follow-up (T2), and at a 2-months follow-up (T3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ameerah Su'ad Abdul Shakor, Universiti Teknologi MARA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2025

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

August 1, 2024

First Submitted That Met QC Criteria

August 1, 2024

First Posted (Actual)

August 6, 2024

Study Record Updates

Last Update Posted (Actual)

April 16, 2025

Last Update Submitted That Met QC Criteria

April 12, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 24-01859-NQ7

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data (IPD) underlying the published study results may be considered for sharing but will not be distributed without the consent of Universiti Teknologi Mara, the Ministry of Health Malaysia, and the Department of Orang Asli Development. Other researchers must first obtain permission from these entities. The datasets generated or analyzed during this study will not contain any identifiers and will be made available to other researchers upon request after receiving their approval. The decision regarding the extent of data to be shared will be based on the reasonableness of the request. Participants can request access to their own individual results but not to those of other participants. Additionally, participants may request access to the general final study findings or to published articles resulting from the study.

IPD Sharing Time Frame

Data will become available after the study results publication date and will remain accessible for up to 7 years following that date.

IPD Sharing Access Criteria

Permission must be obtained from Universiti Teknologi Mara, the Ministry of Health Malaysia, and the Department of Orang Asli Development before access to the IPD is granted. Other researchers interested in accessing the datasets must submit a request outlining the purpose of their research. The decision to share data will be based on the reasonableness and scientific merit of the request. Access is limited strictly to anonymized IPD underlying the published study results.

IPD Sharing Supporting Information Type

  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Attitude

Clinical Trials on Outbreak Preparedness Intervention for the Orang Asli

Subscribe